BBCNEWS BBC News November 6, 2021 01:19:00
Im act. �* . ~ for these drugs to have an imact. �* ., ~ ., impact. and what kind of patients _ impact. and what kind of patients are _ impact. and what kind of patients are going - impact. and what kind of patients are going to - impact. and what kind of. patients are going to benefit from this drug was to mark in the studies, but the study of the studies, but the study of the pfizer drug paxlovid as well as merck's molnupiravir, they focused on people who are at high risk for developing severe covid, so maybe they were obese or had diabetes or other chronic underlying medical conditions....
Source: archive.org
